Dr Arturas Volianskis

2024

• Ingram, R. and Volianskis, A. 2024. Promiscuous involvement of metabotropic glutamate receptors in the storage of N-methyl-d-aspartate receptor-dependent short-term potentiation. Philosophical Transactions of the Royal Society B: Biological Sciences 379, article number: 20230445. (10.1098/rstb.2023.0445)
• Ingram, R., Volianskis, R., Georgiou, J., Jane, D. E., Michael-Titus, A. T., Collingridge, G. L. and Volianskis, A. 2024. Incremental induction of NMDAR-STP and NMDAR-LTP in the CA1 area of ventral hippocampal slices relies on graded activation of discrete NMDA receptors. Philosophical Transactions of the Royal Society B: Biological Sciences 379(1906), article number: 20230239. (10.1098/rstb.2023.0239)

2022

• France, G. et al. 2022. Differential regulation of STP, LTP and LTD by structurally diverse NMDA receptor subunit-specific positive allosteric modulators. Neuropharmacology 202, article number: 108840. (10.1016/j.neuropharm.2021.108840)

2020

• Wang, J. X. et al. 2020. Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors. Nature Communications 11, article number: 423. (10.1038/s41467-020-14321-0)

2019

• Lodge, D., Watkins, J. C., Bortolotto, Z. A., Jane, D. E. and Volianskis, A. 2019. The 1980s: d-AP5, LTP and a Decade of NMDA Receptor Discoveries. Neurochemical Research 44(3), pp. 516-530. (10.1007/s11064-018-2640-6)

2017

• France, G. et al. 2017. Multiple roles of GluN2B-containing NMDA receptors in synaptic plasticity in juvenile hippocampus. Neuropharmacology 112(A), pp. 76-83. (10.1016/j.neuropharm.2016.08.010)

2015

• Volianskis, A., France, G., Jensen, M. S., Bortolotto, Z. A., Jane, D. E. and Collingridge, G. L. 2015. Long-term potentiation and the role of N-methyl-d-aspartate receptors. Brain Research 1621, pp. 5-16. (10.1016/j.brainres.2015.01.016)
• Irvine, M. W. et al. 2015. Synthesis of a series of novel 3,9-disubstituted phenanthrenes as analogues of known N-methyl-d-aspartate receptor allosteric modulators. Synthesis 47(11), pp. 1593-1610. (10.1055/s-0034-1380114)

2014

• Park, P. et al. 2014. NMDA receptor-dependent long-term potentiation comprises a family of temporally overlapping forms of synaptic plasticity that are induced by different patterns of stimulation. Philosophical Transactions of the Royal Society B: Biological Sciences 369(1633), article number: 20130131. (10.1098/rstb.2013.0131)

2013

• Lodge, D. et al. 2013. Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors. Neuropharmacology 74, pp. 135-146. (10.1016/j.neuropharm.2013.03.011)
• Volianskis, A., Collingridge, G. L. and Jensen, M. S. 2013. The roles of STP and LTP in synaptic encoding. PeerJ – the Journal of Life & Environmental Sciences 1, article number: e3. (10.7717/peerj.3)
• Volianskis, A. et al. 2013. Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro. Journal of Physiology 591(4), pp. 955-972. (10.1113/jphysiol.2012.247296)
• Collingridge, G. L. et al. 2013. The NMDA receptor as a target for cognitive enhancement. Neuropharmacology 64, pp. 13-26. (10.1016/j.neuropharm.2012.06.051)

2012

• Ceolin, L., Bortolotto, Z. A., Bannister, N., Collingridge, G. L., Lodge, D. and Volianskis, A. 2012. A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochemistry International 61(4), pp. 517-522. (10.1016/j.neuint.2012.02.035)
• Irvine, M. W. et al. 2012. Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors. Neurochemistry International 61(4), pp. 593-600. (10.1016/j.neuint.2011.12.020)

2010

• Volianskis, A., Køstner, R., Mølgaard, M., Hass, S. and Jensen, M. S. 2010. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis. Neurobiology of Aging 31(7), pp. 1173-1187. (10.1016/j.neurobiolaging.2008.08.005)